Safety and Efficacy of I 0401 in the Treatment of Tibial Plateau Fractures Requiring Grafting

NCT ID: NCT00409799

Last Updated: 2012-03-16

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

208 participants

Study Classification

INTERVENTIONAL

Study Start Date

2006-11-30

Study Completion Date

2011-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

For certain tibial plateau fractures the bone is compressed due to the force acting on the tibia during the accident. The void provoked by the compression of the bone is filled with an appropriate filling material and the fracture is fixated. I 0401 is a new bone graft substitute that has shown capacities to promote bone-healing. This study will test the safety and efficacy of I 0401 in the treatment of patients with tibial plateau fractures requiring grafting.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Tibia Plateau Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

1

Experimental - high dose

Group Type EXPERIMENTAL

I-0401 (a new bone graft substitute)

Intervention Type DRUG

1 time application

2

Experimental - low dose

Group Type EXPERIMENTAL

I-0401 (a new bone graft substitute)

Intervention Type DRUG

1 time application

3

Autograft

Group Type ACTIVE_COMPARATOR

I-0401 (a new bone graft substitute)

Intervention Type DRUG

1 time application

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

I-0401 (a new bone graft substitute)

1 time application

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Radiological evidence of a tibial plateau fracture requiring grafting
* Females of child-bearing potential must be willing to undergo a pregnancy test (urine) prior to treatment start (at screening).

Exclusion Criteria

* Concomitant ipsilateral fractures of the limb other than the fracture of the tibial plateau.
* Active or past history of malignant tumor.
* Evidence of systemic or localized infection at time of surgery.
* Pregnant or lactating females.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Kuros Biosurgery AG

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Peter Messmer, MD

Role: PRINCIPAL_INVESTIGATOR

Zurich University Hospital, Zurich, Switzerland

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Gold Coast Hospital (49)

Gold Coast, Queensland, Australia

Site Status

Princess Alexandra Hospital (45)

Woollongabba, Queensland, Australia

Site Status

Royal Adelaide Hospital (48)

Adelaide, South Australia, Australia

Site Status

Hopital La Cavale Blanche (19)

Brest, , France

Site Status

Hôpital de Dunkerque (30)

Dunkirk, , France

Site Status

Hôpital Central de Nancy (05)

Nancy, , France

Site Status

Hôpital Charles Nicolle (15)

Rouen, , France

Site Status

Charite, Campus Virchow Klinikum (03)

Berlin, , Germany

Site Status

Berufsgenossenschaftliche Unfallklinik Bochum/Duisburg (11)

Duisburg, , Germany

Site Status

Uniklinik Göttingen (22)

Göttingen, , Germany

Site Status

Med. Hochschule Hannover (06)

Hanover, , Germany

Site Status

Universitätsklinikum Schleswig-Holstein (40)

Kiel, , Germany

Site Status

St.-Josef-Krankenhaus (12)

Linnich, , Germany

Site Status

Chirurgische Klinik der LMU (50)

München, , Germany

Site Status

Universitätsklinikum Münster (39)

Münster, , Germany

Site Status

Fövarosi Önkormanyzat Karolyi Sandor Korhaz es Rendelointezet (21)

Budapest, , Hungary

Site Status

Fövarosi Önkormanyzat Peterfy Sandor utcai Korhaz-Rendelöinezet es Baleseti Központ (20)

Budapest, , Hungary

Site Status

Fovárosi Önkormányzat Szent János Kórháza és Észak (54)

Budapest, , Hungary

Site Status

Petz Alandar County Teaching Hospital (55)

Győr, , Hungary

Site Status

Szegedi Egyetem AOK Kari Gyogyszertar (27)

Szeged, , Hungary

Site Status

Istituti Ortopedici Rizzoli (13)

Bologna, , Italy

Site Status

Fondazione Istituto San Raffaele G. Giglio di Cefalù (16)

Cefalù, , Italy

Site Status

A.O. Universitaria San Martino (33)

Genova, , Italy

Site Status

Università degli Studi di Roma "Tor Vergata" (10)

Roma, , Italy

Site Status

A.O. San Giovanni Oddolorata (14)

Roma, , Italy

Site Status

Klinika i Oddzial Kliniczny - Ortopedii i Traumatologii (36)

Krakow, , Poland

Site Status

Oddzial Chirurgii Ortopedyczno-Urazowej - Wojewodzki Szpital Specjalistyczny (58)

Lodz, , Poland

Site Status

SPZOZ Wojewodzki - Specjalistyczny Szpital Chirurgii Urazowej (35)

Piekary Śląskie, , Poland

Site Status

Katedra i Klinika Ortopedii - Traumatologii PAM (34)

Szczecin, , Poland

Site Status

Wojskowy Instytut Medyczny - Centralny Szpital Kliniczny MON (60)

Warsaw, , Poland

Site Status

Katedra I Klinika Ortopedii AM (29)

Warsaw, , Poland

Site Status

Hospital Universitario de la Princesa (18)

Madrid, , Spain

Site Status

Hospital FREMAP Majadahonda (17)

Madrid, , Spain

Site Status

Hospital Universitario Virgen de la Victoria (51)

Málaga, , Spain

Site Status

Hospital FREMAP Sevilla (32)

Seville, , Spain

Site Status

Hospital Universitario La Fe (07)

Valencia, , Spain

Site Status

Zurich University Hospital (01)

Zurich, Canton Zurich, Switzerland

Site Status

Universitätsspital Basel (24)

Basel, , Switzerland

Site Status

Kantonsspital Bruderholz (25)

Bruderholz, , Switzerland

Site Status

CHUV Lausanne (02)

Lausanne, , Switzerland

Site Status

Kantonsspital Luzern (26)

Lucerne, , Switzerland

Site Status

Leeds General Infirmary (04)

Leeds, West Yorkshire, United Kingdom

Site Status

N. Bristol NHS Trust + Univ. of Bristol (52)

Bristol, , United Kingdom

Site Status

University Hospital of Wales (31)

Cardiff, , United Kingdom

Site Status

Norfolk and Norwich University Hospital (44)

Norwich, , United Kingdom

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Australia France Germany Hungary Italy Poland Spain Switzerland United Kingdom

References

Explore related publications, articles, or registry entries linked to this study.

Smith TO, Casey L, McNamara IR, Hing CB. Surgical fixation methods for tibial plateau fractures. Cochrane Database Syst Rev. 2024 Aug 22;8(8):CD009679. doi: 10.1002/14651858.CD009679.pub3.

Reference Type DERIVED
PMID: 39171616 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CS I-040101/02

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Study of Meniscal Allografts
NCT01059409 TERMINATED NA
EVI-01-IT Safety Study
NCT05422976 COMPLETED NA